Transcription factors in airway diseases

104Citations
Citations of this article
86Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Transcription factors regulate the expression of multiple inflammatory genes and play a pivotal role in chronic inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). Prominent transcription factors in airway diseases include nuclear factor-κB (NF-κB) and activator protein-1 (AP-1), which together regulate the expression of multiple inflammatory proteins. Glucocorticoids activate glucocorticoid receptors (GR), which act as transcription factors and inhibit transcription induced by NF-κB and AP-1. Activation of genes involves hyperacetylation of core histones to open up the chromatin structure to initiate transcription. GR recruit histone deacetylase-2 (HDAC2) to the activated inflammatory gene to switch off transcription. In COPD, there is a marked reduction in HDAC2 expression, resulting in glucocorticoid resistance. Therapeutic implications, which may be generalized to all inflammatory diseases, are discussed. © 2006 USCAP, Inc All rights reserved.

Cite

CITATION STYLE

APA

Barnes, P. J. (2006, September 5). Transcription factors in airway diseases. Laboratory Investigation. Nature Publishing Group. https://doi.org/10.1038/labinvest.3700456

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free